Name
Update from the DEA Diversion Control Division
Date & Time
Wednesday, April 4, 2018, 11:15 AM - 12:30 PM
Speakers
James Arnold, MA, Chief, Liaison and Policy Section, Office of Diversion Control, U.S. Drug Enforcement Administration
Sean T. Fearns, Chief, Community Outreach Section, Office of Congressional and Public Affairs, U.S. Drug Enforcement Administration
Sean T. Fearns, Chief, Community Outreach Section, Office of Congressional and Public Affairs, U.S. Drug Enforcement Administration
Description
Moderator: Jackie L. Steele, Jr., JD, Commonwealth Attorney, Kentucky 27th Judicial Circuit, and Member, Operation UNITE Board of Directors
CE Certified by: AAFP, GA Bar, GA POST
Participants will be presented with the latest information on the opioid crisis from the perspective of the U.S. Drug Enforcement Administration (DEA). The session will include an overview of steps that the DEA Diversion Control Division is taking to address the crisis, as well as free, science-based opioid misuse prevention resources available to communities.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Discuss the latest statistics and trends in opioid diversion from the DEA Diversion Control Division.
- Explain the upcoming DEA Rx drug take back effort and upcoming practitioner diversion awareness conferences.
- Describe the free, science-based Operation Prevention opioid awareness program for schools and families, as well as opioid-specific drug education materials available at no cost from DEA.
CE Certified by: AAFP, GA Bar, GA POST
Participants will be presented with the latest information on the opioid crisis from the perspective of the U.S. Drug Enforcement Administration (DEA). The session will include an overview of steps that the DEA Diversion Control Division is taking to address the crisis, as well as free, science-based opioid misuse prevention resources available to communities.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Discuss the latest statistics and trends in opioid diversion from the DEA Diversion Control Division.
- Explain the upcoming DEA Rx drug take back effort and upcoming practitioner diversion awareness conferences.
- Describe the free, science-based Operation Prevention opioid awareness program for schools and families, as well as opioid-specific drug education materials available at no cost from DEA.